Consistent with reports in breast and prostate cancer indicating that metformin suppresses c-Myc expression through miRNA-mediated inhibition [36] or post-translational modification [37], we show that metformin reduces c-Myc expression in ovarian cancer specifically under normoglycemic conditions. This evidence concerns the gene MYC and prostate carcinoma.